KNTK Q1 2026 Earnings Significant EPS Miss as Company Posts Surprise Loss TM Q1 2026 Earnings EPS Beat Driven by Cost Controls and Robust Global Sales ALOY Q1 2024 Earnings EPS Misses Expectations as Company Reports Loss CRESY Q1 2026 Earnings Strong EPS Amid Limited Disclosure Stock Slightly Down Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline ARTNA Q3 2025 Earnings Slight EPS Beat Amid Steady Utility Performance